Media Center
Analyst Views

Analyst Views

28 Nov 16
By Fiona Chisholm, Analyst for GBI Research
Repurposing Type 2 Diabetes Mellitus Drugs for Alzheimer’s Disease

In this Analyst View, Fiona Chisholm, Analyst for GBI Research, discusses the potential for type 2 diabetes drugs to be used in Alzheimer's disease.

Read post
21 Nov 16
By Adam Bradbury, Associate Analyst for GBI Research
Urological Cancer Treatment Landscape to be Transformed by the Approval of Immune Checkpoint Inhibitors

In this Analyst View, Adam Bradbury, Associate Analyst for GBI Research, discuses current trends in the uro-oncology pipeline.

Read post
31 Aug 16
By Fiona Chisholm, Analyst for GBI Research
Do Expedited Drug Development Programs Do More Harm Than Good?

In this Analyst View, Fiona Chisholm, Analyst for GBI Research, discusses the effectiveness of drug development programs.

Read post
29 Jul 16
By Yasser Mushtaq, Senior Analyst for GBI Research
Respiratory Disorders Set to Benefit from Influx of Novel Targeted Biologic Therapies

In this Analyst View, Yasser Mushtaq, Senior Analyst for GBI Research, discusses the respiratory therapy area and the novel targeted biologic therapies that are starting to transform it.

Read post
29 Jul 16
By Qaisrah Khalid, Associate Analyst for GBI Research
Ophthalmology: New Molecular Targets to Reshape the Clinical and Commercial Landscape

In this Expert Insight, Qaisrah Khalid, Associate Analyst for GBI Research, discusses the ophthalmology therapy space and its current trajectory in term of its clinical and commercial landscape.

Read post